| Identification | Back Directory | [Name]
2-Propynamide, 3-[5-[(4aR,8aS)-3,4,4a,5,8,8a-hexahydro-3-(1-methylethyl)-4-oxo-1-phthalazinyl]-2-methoxyphenyl]-N-(phenylmethyl)-, rel- | [CAS]
2376326-31-5 | [Synonyms]
NPD-1335
2-Propynamide, 3-[5-[(4aR,8aS)-3,4,4a,5,8,8a-hexahydro-3-(1-methylethyl)-4-oxo-1-phthalazinyl]-2-methoxyphenyl]-N-(phenylmethyl)-, rel- | [Molecular Formula]
C28H29N3O3 | [MOL File]
2376326-31-5.mol | [Molecular Weight]
455.55 |
| Chemical Properties | Back Directory | [density ]
1.17±0.1 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
Soluble in DMSO | [form ]
Solid | [pka]
12.42±0.46(Predicted) | [color ]
Off-white to light yellow |
| Hazard Information | Back Directory | [Description]
NPD1335 is a Trypanosoma brucei phosphodiesterase B1 (TbrPDEB1) inhibitor with submicromolar activities against T. brucei parasites. NPD1335 displays a greatly improved cytotoxicity profile. NPD1335 increases intracellular cAMP levels and results in the distortion of the cell cycle and cell death[1].
pKi: 6.9 (TbrPDEB1); pIC50: 6.2 (T. brucei) (NPD-1335)[1] | [References]
[1]. de Heuvel E, et al. Alkynamide phthalazinones as a new class of TbrPDEB1 inhibitors (Part 2). Bioorg Med Chem. 2019 Jul 5. pii: S0968-0896(19)30790-4. |
|
|